Is SAVAW or NOBL a better dividend investment in 2026?

SAVAW currently yields 6666.67% with a 5% 5-year dividend growth rate. NOBL yields 2.14% with 5% growth. The better choice depends on your goal: SAVAW offers higher current income.

What is the dividend yield difference between SAVAW and NOBL?

SAVAW has a forward dividend yield of 6666.67% ($2.00/share annually). NOBL yields 2.14% ($2.27/share annually). The yield gap is 6664.53 percentage points.

Home › Compare › SAVAW vs NOBL

SAVAW vs NOBL: Dividend Comparison 2026

SAVAW yields 6666.67% · NOBL yields 2.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SAVAW wins by $1028095347812062.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

SAVAW

● Live price

6666.67%

Share price

$0.03

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1028095347812062.00M

Annual income

$998,628,545,336,266,700,000.00

Full SAVAW calculator →

NOBL

● Live price

2.14%

Share price

$106.01

Annual div

$2.27

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$22.8K

Annual income

$246.19

Full NOBL calculator →

Portfolio growth — SAVAW vs NOBL

📍 SAVAW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SAVAW	NOBL
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SAVAW + NOBL cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SAVAW pays

NOBL pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SAVAW

Annual income on $10K today (after 15% tax)

$566,666.67/yr

After 10yr DRIP, annual income (after tax)

$848,834,263,535,826,600,000.00/yr

NOBL

Annual income on $10K today (after 15% tax)

$182.19/yr

After 10yr DRIP, annual income (after tax)

$209.26/yr

At 15% tax rate, SAVAW beats the other by $848,834,263,535,826,600,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SAVAW + NOBL for your $10,000?

SAVAW: 50%NOBL: 50%

100% NOBL50/50100% SAVAW

Portfolio after 10yr

$514047673906031.00M

Annual income

$499,314,272,668,133,360,000.00/yr

Blended yield

97.13%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SAVAW buys

NOBL buys

No recent congressional trades found for SAVAW or NOBL in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSAVAWNOBL

Forward yield	6666.67% ✓	2.14%
Annual dividend / share	$2.00	$2.27 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$1028095347812062.00M ✓	$22.8K
Annual income after 10y	$998,628,545,336,266,700,000.00 ✓	$246.19
Total dividends collected	$1026118102492338.88M ✓	$2.3K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: SAVAW vs NOBL ($10,000, DRIP)

Year	SAVAW Portfolio	SAVAW Income/yr	NOBL Portfolio	NOBL Income/yr	Gap
1← crossover	$677,367	$666,666.67	$10,914	$214.34	+$666.5K → SAVAW
2	$42,928,313	$42,203,530.63	$11,897	$218.63	+$42.92M → SAVAW
3	$2,545,616,701	$2,499,683,405.64	$12,952	$222.72	+$2545.60M → SAVAW
4	$141,255,910,403	$138,532,100,533.89	$14,086	$226.62	+$141255.90M → SAVAW
5	$7,335,374,338,812	$7,184,230,514,680.15	$15,302	$230.33	+$7335374.32M → SAVAW
6	$356,516,885,536,661	$348,668,034,994,132.70	$16,607	$233.85	+$356516885.52M → SAVAW
7	$16,218,956,689,966,618	$15,837,483,622,442,392.00	$18,007	$237.18	+$16218956689.95M → SAVAW
8	$690,711,023,145,868,900	$673,356,739,487,604,600.00	$19,508	$240.35	+$690711023145.85M → SAVAW
9	$27,539,067,734,387,980,000	$26,800,006,939,621,900,000.00	$21,116	$243.35	+$27539067734387.96M → SAVAW
10	$1,028,095,347,812,062,000,000	$998,628,545,336,266,700,000.00	$22,841	$246.19	+$1028095347812062.00M → SAVAW

SAVAW vs NOBL: Complete Analysis 2026

SAVAW — Stock

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. The company was incorporated in 1998 and is based in Austin, Texas.

Full SAVAW Calculator →

NOBL — ETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →

📬

Get this SAVAW vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SAVAW vs SCHD SAVAW vs JEPI SAVAW vs O SAVAW vs KO SAVAW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.